FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117524902> ?p ?o ?g. }

• W2117524902 endingPage "6362" @default.
• W2117524902 startingPage "6357" @default.
• W2117524902 abstract "To determine the prevalence of mammalian target of rapamycin phosphorylation (p-mTOR) and vascular endothelial growth factor (VEGF) and any correlation with clinical characteristics and prognosis in ovarian clear cell carcinoma patients.Seventy four paraffin-embedded specimens of such carcinomas frompatients who underwent surgery, received adjuvant chemotherapy and were followed up at King Chulalongkorn Memorial Hospital during January 2002 to December 2008 were stained with rabbit monoclonal IgG p-mTOR and rabbit polyclonal IgG VEGF using immunohistochemical methods. Medical records were reviewed and clinical variables were analysed.The prevalence of positive p-mTOR in ovarian clear cell carcinoma was 87.9% and significantly higher in advance-stage than early-stage patients (100% versus 83.6%, P<0.05). Two-year disease free survival and 2-year overall survival in patients with positive p-mTOR expression were 60% and 69.2% with no differences from patients with negative p-mTOR expression (p>0.05). The prevalence of VEGF expression was 63.5% and significantly higher in chemo-sensitive than chemo-resistant patients (70.7% versus 37.5%, P<0.05). Two-year disease free survival and 2-year overall survival in patients with VEGF expression were 72.3% and 83% respectively which were significantly different from patients with negative VEGF expression (p<0.05 ).p-mTOR expression in ovarian clear cell carcinoma was significantly correlated with the stage of disease. VEGF expression was significantly correlated with chemosensitivity, and survival. Further studies of related targeted therapy might be promising." @default.
• W2117524902 created "2016-06-24" @default.
• W2117524902 creator A5015126806 @default.
• W2117524902 creator A5058529546 @default.
• W2117524902 creator A5084596036 @default.
• W2117524902 date "2012-12-31" @default.
• W2117524902 modified "2023-09-24" @default.
• W2117524902 title "Prevalence and Clinical Significance of Mammalian Target of Rapamycin Phosphorylation (p-mTOR) and Vascular Endothelial Growth Factor (VEGF) in Clear Cell Carcinoma of the Ovary" @default.
• W2117524902 cites W1968109047 @default.
• W2117524902 cites W1968381227 @default.
• W2117524902 cites W1978597789 @default.
• W2117524902 cites W1983414305 @default.
• W2117524902 cites W1984043093 @default.
• W2117524902 cites W1996193504 @default.
• W2117524902 cites W2001877789 @default.
• W2117524902 cites W2005479935 @default.
• W2117524902 cites W2011485783 @default.
• W2117524902 cites W2013453542 @default.
• W2117524902 cites W2023231438 @default.
• W2117524902 cites W2025137878 @default.
• W2117524902 cites W2045779236 @default.
• W2117524902 cites W2047624932 @default.
• W2117524902 cites W2057087136 @default.
• W2117524902 cites W2088363975 @default.
• W2117524902 cites W2088561077 @default.
• W2117524902 cites W2103540939 @default.
• W2117524902 cites W2110604215 @default.
• W2117524902 cites W2116870857 @default.
• W2117524902 cites W2119402989 @default.
• W2117524902 cites W2136090166 @default.
• W2117524902 cites W2160581690 @default.
• W2117524902 cites W2166684048 @default.
• W2117524902 doi "https://doi.org/10.7314/apjcp.2012.13.12.6357" @default.
• W2117524902 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23464458" @default.
• W2117524902 hasPublicationYear "2012" @default.
• W2117524902 type Work @default.
• W2117524902 sameAs 2117524902 @default.
• W2117524902 citedByCount "4" @default.
• W2117524902 countsByYear W21175249022015 @default.
• W2117524902 countsByYear W21175249022023 @default.
• W2117524902 crossrefType "journal-article" @default.
• W2117524902 hasAuthorship W2117524902A5015126806 @default.
• W2117524902 hasAuthorship W2117524902A5058529546 @default.
• W2117524902 hasAuthorship W2117524902A5084596036 @default.
• W2117524902 hasBestOaLocation W21175249021 @default.
• W2117524902 hasConcept C121608353 @default.
• W2117524902 hasConcept C126322002 @default.
• W2117524902 hasConcept C142724271 @default.
• W2117524902 hasConcept C143998085 @default.
• W2117524902 hasConcept C146285616 @default.
• W2117524902 hasConcept C146357865 @default.
• W2117524902 hasConcept C151730666 @default.
• W2117524902 hasConcept C167734588 @default.
• W2117524902 hasConcept C190283241 @default.
• W2117524902 hasConcept C204232928 @default.
• W2117524902 hasConcept C2777025900 @default.
• W2117524902 hasConcept C2777546739 @default.
• W2117524902 hasConcept C2777982462 @default.
• W2117524902 hasConcept C2780427987 @default.
• W2117524902 hasConcept C2781199814 @default.
• W2117524902 hasConcept C3019054536 @default.
• W2117524902 hasConcept C502942594 @default.
• W2117524902 hasConcept C55493867 @default.
• W2117524902 hasConcept C71924100 @default.
• W2117524902 hasConcept C86554907 @default.
• W2117524902 hasConcept C86803240 @default.
• W2117524902 hasConceptScore W2117524902C121608353 @default.
• W2117524902 hasConceptScore W2117524902C126322002 @default.
• W2117524902 hasConceptScore W2117524902C142724271 @default.
• W2117524902 hasConceptScore W2117524902C143998085 @default.
• W2117524902 hasConceptScore W2117524902C146285616 @default.
• W2117524902 hasConceptScore W2117524902C146357865 @default.
• W2117524902 hasConceptScore W2117524902C151730666 @default.
• W2117524902 hasConceptScore W2117524902C167734588 @default.
• W2117524902 hasConceptScore W2117524902C190283241 @default.
• W2117524902 hasConceptScore W2117524902C204232928 @default.
• W2117524902 hasConceptScore W2117524902C2777025900 @default.
• W2117524902 hasConceptScore W2117524902C2777546739 @default.
• W2117524902 hasConceptScore W2117524902C2777982462 @default.
• W2117524902 hasConceptScore W2117524902C2780427987 @default.
• W2117524902 hasConceptScore W2117524902C2781199814 @default.
• W2117524902 hasConceptScore W2117524902C3019054536 @default.
• W2117524902 hasConceptScore W2117524902C502942594 @default.
• W2117524902 hasConceptScore W2117524902C55493867 @default.
• W2117524902 hasConceptScore W2117524902C71924100 @default.
• W2117524902 hasConceptScore W2117524902C86554907 @default.
• W2117524902 hasConceptScore W2117524902C86803240 @default.
• W2117524902 hasIssue "12" @default.
• W2117524902 hasLocation W21175249021 @default.
• W2117524902 hasLocation W21175249022 @default.
• W2117524902 hasOpenAccess W2117524902 @default.
• W2117524902 hasPrimaryLocation W21175249021 @default.
• W2117524902 hasRelatedWork W2070758284 @default.
• W2117524902 hasRelatedWork W2082308871 @default.
• W2117524902 hasRelatedWork W2144075358 @default.
• W2117524902 hasRelatedWork W2361295176 @default.
• W2117524902 hasRelatedWork W2363776757 @default.
• W2117524902 hasRelatedWork W2392948432 @default.

• next